Visceral fat is the fat found in the abdominal cavity and can pose serious health risks over time. One of the only ways to manage or even get rid of this type of fat in the body is through making dietary changes.
When it comes to losing visceral fat, Express reports that there is one big contributor to the accumulation of this kind of fat in the body; sugar. Sugar, especially refined sugars, is one of the worst enemies when it comes to shedding the visceral fat in the body. A lot of studies have further backed this up, finding that people who have added sugar in their diets tend to have more visceral fat compared to those who do not or at least take less sugar in their diets.
As to what makes sugar this dangerous when it comes to losing visceral fat, it all boils down to one compound in this ingredient: Fructose. A lot of fructose will turn into fat when it gets to the liver, adding up to the visceral fat a person may have in their abdomen.
So, with that in mind, the key to getting rid of visceral fat is to reducing or cutting out sugar intake in a diet. Along with reducing sugar intake, experts recommend increasing protein intake for overall weight loss and not just visceral fat. Eating more protein, as studies have shown, will suppress appetite and reduce the cravings a person may have in between. Lean meat, dairy, fish, nuts, and beans and legumes are good sources of protein.
Diet and exercise may be a big factor in losing visceral fat, but Express also reports that the amount of sleep a person gets also plays a part in losing weight. The recommended amount of sleep for a healthy lifestyle is seven to eight hours. A study spanning six years showed that people who got seven to eight hours of sleep every night gained less visceral fat by about 26 percent.
This also backs up the fact that less sleep means a bigger risk of developing visceral fat in the body. According to experts, those who sleep less than five hours tend to gain more weight over a span of five years.


GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP
U.S. Issues Cuba Health Alert as Illnesses Rise
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
3 clinical-grade skincare creams you really shouldn’t buy online
Trump Signs Order to Cut Routine Childhood Vaccines
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
France Keeps Top Health Alert as Officials Brace for Another Heatwave 



